APA (7th ed.) Citation

Sahu, N., Stephan, J., Cruz, D. D., Merchant, M., Haley, B., Bourgon, R., . . . Settleman, J. (2016). Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs. Nature Portfolio.

Chicago Style (17th ed.) Citation

Sahu, Nisebita, Jean-Philippe Stephan, Darlene Dela Cruz, Mark Merchant, Benjamin Haley, Richard Bourgon, Marie Classon, and Jeff Settleman. Functional Screening Implicates MiR-371-3p and Peroxiredoxin 6 in Reversible Tolerance to Cancer Drugs. Nature Portfolio, 2016.

MLA (8th ed.) Citation

Sahu, Nisebita, et al. Functional Screening Implicates MiR-371-3p and Peroxiredoxin 6 in Reversible Tolerance to Cancer Drugs. Nature Portfolio, 2016.